INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 240 filers reported holding INSMED INC in Q3 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $13,674 | -3.2% | 802 | +13.4% | 0.00% | – |
Q4 2022 | $14,126 | -5.8% | 707 | 0.0% | 0.00% | – |
Q3 2022 | $15,000 | +7.1% | 707 | 0.0% | 0.00% | – |
Q2 2022 | $14,000 | -17.6% | 707 | 0.0% | 0.00% | – |
Q1 2022 | $17,000 | -10.5% | 707 | 0.0% | 0.00% | – |
Q4 2021 | $19,000 | 0.0% | 707 | 0.0% | 0.00% | – |
Q3 2021 | $19,000 | -13.6% | 707 | -10.2% | 0.00% | – |
Q2 2021 | $22,000 | -18.5% | 787 | 0.0% | 0.00% | – |
Q1 2021 | $27,000 | +8.0% | 787 | +3.6% | 0.00% | – |
Q4 2020 | $25,000 | – | 760 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |